Selected publications
-
Cell signaling-based classifier predicts response to induction therapy in elderly patients with acute myeloid leukemia.
PLoS ONE.
2015
Academic Article
GET IT
Times cited: 4 -
Fate of Patients with Newly Diagnosed Acute Myeloid Leukemia Who Fail Primary Induction Therapy.
Biology of Blood and Marrow Transplantation.
2015
Academic Article
GET IT
Times cited: 18 -
Four different regimens of farnesyltransferase inhibitor tipifarnib in older, untreated acute myeloid leukemia patients: North American Intergroup Phase II study SWOG S0432.
Leukemia Research.
2014
Academic Article
GET IT
Times cited: 10 -
Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy.
British Journal of Haematology.
2014
Academic Article
GET IT
Times cited: 23 -
Imatinib 800 mg daily induces deeper molecular responses than imatinib 400 mg daily: Results of SWOG S0325, an intergroup randomized PHASE II trial in newly diagnosed chronic phase chronic myeloid leukaemia.
British Journal of Haematology.
2014
Academic Article
GET IT
Times cited: 41 -
A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia.
Blood.
2013
Academic Article
GET IT
Times cited: 279 -
A randomized trial of dasatinib 100 mg versus imatinib 400 mg in newly diagnosed chronic-phase chronic myeloid leukemia.
Blood.
2012
Academic Article
GET IT
Times cited: 119 -
ret/PTC activation is not associated with individual radiation dose estimates in a pilot study of neoplastic thyroid nodules arising in Russian children and adults exposed to Chernobyl fallout.
Thyroid.
2008
Academic Article
GET IT
Times cited: 20 -
The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations.
British Journal of Haematology.
2006
Academic Article
GET IT
Times cited: 154 -
Microarray comparative genomic hybridization reveals genome-wide patterns of DNA gains and losses in post-chernobyl thyroid cancer.
Radiation Research.
2006
Academic Article
GET IT
Times cited: 19 -
Revised Recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia.
Journal of Clinical Oncology.
2003
Review
GET IT
Times cited: 1721 -
Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2'-deoxycoformycin and prediction of early relapse.
Clinical Cancer Research.
1999
Academic Article
GET IT
Times cited: 78